Vivani Medical, Inc.

Vivani Medical, Inc.

VANI·NASDAQ

$1.28

+0.39%
HealthcareMedical - Devices

Vivani Medical, Inc., a clinical stage company, develops various implants that treat chronic diseases with high unmet medical need. It engages in developing a portfolio of miniature drug implants to deliver minimally fluctuating drug profiles; and implantable visual prostheses devices to deliver useful artificial vision to blind individuals. The company is headquartered in Emeryville, California.

At a Glance

Live Snapshot
Market Cap$75.92M
EPS-0.4300
P/E Ratio-2.99
Earnings Date08/12/2026

vani

Net Common Stock Issuance

Last Annual Value

23.26M

3-Year CAGR

1033%

5-Year CAGR

22%

10-Year CAGR

23%

Vivani Medical, Inc.

Vivani Medical, Inc. Competitors Analysis of Net Common Stock Issuance

VANI · NASDAQ
CompanyNet Common Stock Issuance
CAGR 3Y
CAGR 5Y
CAGR 10Y
23.26M
459.2%14.9%1.3% 
86.24M
136.0%N/AN/A
CLNN logo
Clene Inc.
NASDAQ:CLNN
10.40M
-37.2%2.4%N/A
CRVO logo
CervoMed Inc.
NASDAQ:CRVO
46.40M
285.5%8.3%N/A
12.23M
157.5%-22.6%N/A
1.00M
N/A-25.9%N/A
13.41M
58.8%-1.7%N/A
XBIT logo
XBiotech Inc.
NASDAQ:XBIT
0.00
N/AN/AN/A
107.39M
89.8%41.9%N/A
-1.81M
N/AN/AN/A
-130.50K
N/AN/AN/A
Vivani Medical, Inc.

Vivani Medical, Inc. Fair Value Envelope

VANI · NASDAQ

Our analysis suggests that VANI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $1.285, this represents a potential HIDDEN relative to our calculated worth for Vivani Medical, Inc..

Intrinsic Value
Current Price: $1.285